Cargando…

Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma

SIMPLE SUMMARY: Uterine serous carcinomas (USC) represent a rare and aggressive subtype of uterine cancer. Patients often receive adjuvant therapy including chemotherapy and/or radiation after surgery, which has limited efficacy in preventing high rates of recurrence. Understanding the tumor microen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bloom, Elizabeth A., Peters, Pamela N., Whitaker, Regina, Russell, Shonagh, Albright, Benjamin, Cummings, Shelly, Timms, Kirsten M., Slavin, Thomas, Probst, Braden, Strickland, Kyle C., Previs, Rebecca A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856872/ https://www.ncbi.nlm.nih.gov/pubmed/36672477 http://dx.doi.org/10.3390/cancers15020528

Ejemplares similares

The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma
por: da Silva, Jesse Lopes, et al.
Publicado: (2021)

Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer
por: Russell, Shonagh, et al.
Publicado: (2022)

PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer
por: Jones, Wendell, et al.
Publicado: (2022)

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
por: Dai, Danian, et al.
Publicado: (2021)

Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative
por: Spinosa, Daniel, et al.
Publicado: (2021)

Paratubal serous borderline tumor
por: Shin, You-Jung, et al.
Publicado: (2011)

The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer
por: Belotti, Yuri, et al.
Publicado: (2022)

Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors
por: Kogan, Liron, et al.
Publicado: (2018)

xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma
por: Sugiyama, Akiko, et al.
Publicado: (2020)

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma
por: Pelligra, Silvia, et al.
Publicado: (2020)

Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors
por: Kim, Hyunjin, et al.
Publicado: (2021)

Pathogenesis and Clinical Management of Uterine Serous Carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer
por: Aquino-Acevedo, Alexandra N., et al.
Publicado: (2022)

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
por: Santin, A D, et al.
Publicado: (2005)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
por: Strickland, Kyle C., et al.
Publicado: (2016)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
por: Toor, Salman M., et al.
Publicado: (2021)

Serous borderline tumor of the fallopian tube
por: Choi, So Mi, et al.
Publicado: (2014)

BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2019)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Papillary Serous Carcinoma of the Uterine Cervix with Lung Metastasis
por: Khan, Maliha, et al.
Publicado: (2014)

Improved survival of patients with hypermutation in uterine serous carcinoma
por: Santin, Alessandro D., et al.
Publicado: (2015)

Adrenal Metastasis from Uterine Papillary Serous Carcinoma
por: Lubana, Sandeep Singh, et al.
Publicado: (2016)

The role of omentectomy in the surgical treatment of uterine serous carcinoma
por: Chen, Ming, et al.
Publicado: (2019)

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

Prognostic impact of tumor-infiltrating lymphocytes in high grade serous ovarian cancer: a systematic review and meta-analysis
por: Hao, Jiatao, et al.
Publicado: (2020)

Uterine Serous Adenocarcinoma in an Elderly Postmenopausal Woman: Clinically Misdiagnosed as Uterine Cervix Cancer
por: Hong, Jeong-A, et al.
Publicado: (2015)

Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
por: Chui, M. Herman, et al.
Publicado: (2021)

Serous adenocarcinoma of the fallopian tube, associated with verrocous carcinoma of the uterine cervix: a case report of synchronic rare gynecological tumors
por: Cantu de Leon, David, et al.
Publicado: (2009)

Multiple brain metastases in a patient with uterine papillary serous adenocarcinoma: Treatment options for this rarely seen metastatic brain tumor
por: Gulsen, Salih, et al.
Publicado: (2013)

Uterine Tumor—Case
Publicado: (1874)

Treatment of Uterine Tumors
por: Byford, Wm. H.
Publicado: (1865)

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
por: Santin, A D, et al.
Publicado: (2004)

Serous carcinoma of the uterine cervix: Clinicopathological features differing from serous carcinomas of other female organs
por: Kitade, Shoko, et al.
Publicado: (2019)

An uncommon paratubal cyst: Serous borderline tumor
por: Limaiem, Faten, et al.
Publicado: (2023)

The Continuum of Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary
por: Wong, Kwong-Kwok, et al.
Publicado: (2007)

Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case series
por: Albright, Benjamin B., et al.
Publicado: (2023)

Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
por: Kim, Ki Hyung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4dgj26pg60114agg3dq93vbre9